No Gain From P-Selectin-Blocking Agent in Hospitalized COVID No Gain From P-Selectin-Blocking Agent in Hospitalized COVID

Treatment with crizanlizumab didn ' t improve survival or days free of cardiopulmonary support in patients hospitalized with COVID-19 in a randomized study.Medscape Medical News
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Infectious Diseases News Source Type: news